Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats

BMC Pharmacology

Volumn 8, Issue , 2008, Pages

  Koladiya, Rajeshkumar U ^a   Jaggi, Amteshwar S ^a   Singh, Nirmal ^a   Sharma, Bhupesh K ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ATORVASTATIN; CHOLESTEROL; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHIONINE; NITRITE; PITAVASTATIN; HEPTANOIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; PYRROLE DERIVATIVE; QUINOLINE DERIVATIVE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; MALE; MAZE TEST; MEMORY DISORDER; MULTIINFARCT DEMENTIA; NONHUMAN; OXIDATIVE STRESS; RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; MEMORY; PATHOPHYSIOLOGY; THORACIC AORTA; VASCULAR ENDOTHELIUM; WISTAR RAT;

ANIMALS; ANTICHOLESTEREMIC AGENTS; AORTA, THORACIC; DEMENTIA, VASCULAR; ENDOTHELIUM, VASCULAR; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MAZE LEARNING; MEMORY; METHIONINE; PYRROLES; QUINOLINES; RATS; RATS, WISTAR;

EID: 51349101107     PISSN: None     EISSN: 14712210     Source Type: Journal    
DOI: 10.1186/1471-2210-8-14     Document Type: Article

References (66)

1. Davignon J Ganz P Role of Endothelial Dysfunction in Atherosclerosis Circulation 2004, 109:27-32 10.1161/01.CIR.0000115644.35804.8B 15198963
2. Bottiglieri T Diaz-Arrastia R Hyperhomocysteinemia and cognitive function: More than just a casual link Am J Clin Nutr 2005, 82:493-4 16155257
3. Homocysteine Studies Collaboration Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis JAMA 2002, 288:2015-22 10.1001/ jama.288.16.2015 12387654
4. Isobe T Murata C Sato Y Terayama Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease Life Sciences 2005, 77(15):1836C-43C 10.1016/j.lfs.2005.02.014
5. Abahji TN Nill L Ide N Keller C Hoffmann U Weiss N Acute Hyperhomocysteinemia Induces Microvascular and Macrovascular Endothelial Dysfunction Arch Med Res 2007, 38:411-6 10.1016/j.arcmed.2007.01.004 17416288
6. Corzo L Zas R Rodr'ýguez S Fern'andez-Novoa L Cacabelos R Decreased levels of serum nitric oxide in different forms of dementia Neurosci Lett 2007, 420:263-7 10.1016/j.neulet.2007.05.008 17556102
7. Dayal S Devlin AM McCaw RB Liu ML Arning E Bottiglieri T Shane B Faraci FM Lentz SR Cerebral Vascular Dysfunction in Methionine Synthase Deficient Mice Circulation 2005, 112:737-44 10.1161/ CIRCULATIONAHA.104.529248 16043641
8. Lee H Kim HJ Kim J Chang N Effects of dietary folic acid supplementation on cerebrovascular endothelial dysfunction in rats with induced hyperhomocysteinemia Brain Res 2004, 996:139-47 10.1016/ j.brainres.2003.10.027 14697491
9. Corder EH Saunders AM Strittmatter WJ Schmechel DE Gaskell PC Gene dose of apolipoprotein E type 4 allele and risk of Alzheimer's disease in late onset families Science 1993, 261:921-3 10.1126/science.8346443 8346443
10. Hirche F Schröder A Knoth B Stang GI Eder K Effect of dietary methionine on plasma and liver cholesterol concentrations in rats and expression of hepatic genes involved in cholesterol metabolism Br J Nut 2006, 95:879-88 10.1079/BJN20061729
11. Shobab LA Hsiung GR Feldman HH Cholesterol in Alzheimer's Disease Lancet Neurol 2005, 4:841-52 10.1016/S1474-4422(05)70248-9 16297842
12. Korczyn AD Kalvach P Bornstein ND Vascular dementia 2003 J Neurol Sci 2005, 229-230:1-2
13. Parle M Singh N Reversal of memory deficits by atorvastatin and simvastatin in rats Yakugaku Zasshi 2007, 127:1125-37 10.1248/ yakushi.127.1125 17603272
14. Miida T Takahashi A Ikeuchi T Prevention of stroke and dementia by statin therapy: Experimental and clinical evidence of their pleiotropic effects Pharmacol Therapeut 2007, 113:378-93 10.1016/ j.pharmthera.2006.09.003 17113151
15. Vaughan CJ Prevention of Stroke and Dementia with Statins: Effects Beyond Lipid Lowering Am J Cardiol 2003, 91(Suppl):23B-9B 10.1016/ S0002-9149(02)03270-8 12615295
16. Austen B Christodoulou G Terry JE Relation between cholesterol levels, statins and Alzheimer's disease in the human population J Nutr Health Aging 2002, 6:377-82 12459888
17. Wagstaff LR Mitton MW Arvik BM Doraiswamy PM Statin-associated memory loss: Analysis of 60 case reports and review of the literature Pharmacotherapy 2003, 23:871-80 10.1592/phco.23.7.871.32720 12885101
18. Muldoon MF Barger SD Ryan CM Flory JD Lehoczky JP Matthews KA Manuck SB Effects of lovastatin on cognitive function and psychological well-being Am J Med 2000 ,108:538-46 10.1016/S0002-9343(00)00353-3 10806282
19. Bayten SH Alkant M Ozeren M Ekinci M Akgun A Fluvastatin Alters Psychomotor Performance and Daily Activity but not the Spatial Memory in Rats Tohoku J Exp Med 2006, 209:311-20 10.1620/tjem.209.311 16864953
20. Vanhoutte PM Aging and endothelial dysfunction European Heart J 2004, 4:A8-A17 10.1016/S1520-765X(02)90068-4
21. Gingerich S Krukoff TL Estrogen modulates endothelial and neuronal nitric oxide synthase expression via an estrogen receptor beta-dependent mechanism in hypothalamic slice cultures Endocrinology 2005, 146:2933-41 10.1210/en.2004-1375 15790731
22. Morris RGM Development of a water maze producer for studying spatial learning in the rats J Neurosci Meth 1984, 11:47-60 10.1016/ 0165-0270(84)90007-4
23. Parle M Singh N Animal models for testing memory Asia Pacific J Pharmacol 2004, 16:101-22
24. Sastry KVH Moudgal RP Mohan J Tyagi JS Rao GsS Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy Analytical Biochemistry 2002, 306:79-82 10.1006/abio.2002.5676 12069417
25. Sharma B Singh N Singh M Modulation of celecoxib and streptozotocin-induced experimental dementia of Alzheimer's disease type by pitavastatin and donepezil J Psychopharmacol 2008
26. Packard MG Teather LA Bazan NG Effect of intra-striated injections of platelet-activating factor and PAF antagonist BN 52021 on memory Neurobiol Learn Mem 1996, 66:176-82 10.1006/nlme.1996.0058 8946410
27. Streck EL Bavaresco CS Netto CA Wyse AT Chronic hyperhomocysteinemia provokes a memory deficit in rats in the Morris water maze task Behav Brain Res 2004, 153:377-81 10.1016/j.bbr.2003.12.013 15265632
28. Baydas G Ozer M Yasar A Tuzcu M Koz ST Melatonin improves learning and memory performances impaired by hyperhomocysteinemia in rats Brain Res 2005, 1046:187-94 10.1016/j.brainres.2005.04.011 15882843
29. Stefanello FM Monteiro SC Emilene CM Scherer BS Netto CA Wyse ATS Hypermethioninemia Increases Cerebral Acetylcholinesterase Activity and Impairs Memory in Rats Neurochem Res 2007, 32:1868-74 10.1007/ s11064-007-9464-0 17701348
30. Shah DI Singh M Possible role of Akt to improve vascular endothelial dysfunction in diabetic and hyperhomocysteinemic rats Mol Cell Biochem 2007, 295(1-2):65-74 10.1007/s11010-006-9273-9 16841179
31. Shah DI Singh M Inhibition of protein tyrosine phosphatase improves vascular endothelial dysfunction Vascular Pharmacology 2006, 44:177-82 10.1016/j.vph.2005.11.004 16442349
32. Atkinson J Cerebrovascular structure and dementia: New drug targets Trends Pharmacolol Sci 2001, 22:630-5 10.1016/S0165-6147(00)01866-6 11730973
33. Zhu X Smith MA Honda K Aliev G Moreira PI Nunomura A Casadesus G Harris PLR Siedlak SL Perry G Vascular oxidative stress in Alzheimer disease J Neurological Sciences 2007, 257:240-6 10.1016/j.jns.2007.01.039
34. Gauthier S Alzheimer's disease: Current and Future therapeutic perspectives Pmg Nem-Psychopharmnco1 and Bid Psychiat 2001, 25:73-89 10.1016/S0278-5846(00)00149-4 11263760
35. Lipton SA Kim W-K Choi Y-B Kumar S D'emilia DM Rayudu PV Arnelle DR Stamler JS Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor Proc Natl Acad Sci 1997, 94:5923-8 20882 9159176 10.1073/pnas.94.11.5923
36. R Herrmann W Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia FEBS Lett 2006, 580:2994-3005 10.1016/j.febslet.2006.08.020 16697371
37. Wolozin B Behl C Mechanisms of neurodegenerative disorders: Part 1: protein aggregates Arch Neurol 2000, 57:793-6 10.1001/archneur.57.6.793 10867775
38. Laufs U La Fata V Plutzky J Liao JK Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 1998, 97:1129-35 9537338
39. Kureishi Y Luo Z Shiojima I Bialik A Fulton D Lefer DJ Sessa WC Walsh K The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals Nature Medicine 2000, 6:1004-10 10.1038/79510 10973320
40. Hernandez-Perera O Perez-Sala D Navarro-Antolin J Sanchez-Pascuala R Hernandez G Diaz C Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells J Clin Invest 1998, 101:2711-19 508862 9637705 10.1172/ JCI1500
41. Goldstein JL Brown MS Regulation of the mevalonate pathway Nature 1990, 343:425-30 10.1038/343425a0 1967820
42. Wassmann S Laufs U Baumer AT Müller K Ahlbory K Linz WW Litter G Rosen R Bohm M Nickenig G HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species Hypertension 2001, 37:1450-7 11408394
43. Meye C Schumann J Wagner A Gross P Effects of homocysteine on the levels of caveolin-1 and eNOS in caveolae of human coronary artery endothelial cells Atherosclerosis 2006, 190:256-63 16616146 10.1016/ j.atherosclerosis.2006.03.009
44. Von Haehling S Anker SD Bassenge E Statins and the role of nitric oxide in chronic heart failure Heart Fail Rev 2003, 8:99-106 10.1023/ A:1022103222857 12652163
45. Bretillon L Lutjohann D Stahel L Widhe T Bindl L Eggerstsen G Diczfalusy U Bjorkhem I Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface J Lipid Res 2000, 41:840-5 10787445
46. Haley RW Dietschy JM Is there a connection between the concentration of cholesterol circulating in plasma and the rate of neuritic plaque formation in Alzheimer disease? Arch Neurol 2000, 57:1410-12 10.1001/ archneur.57.10.1410 11030791
47. Poirier J Apolipoprotein E in the brain and its role in Alzheimer's disease J psychiatry Neurosci 1996, 21:128-34 1188752 8820179
48. Hofman A Ott A Breteler MMB Bots ML Slooter AJC Harskamp FV Duijin CNV Broeckhoven CV Gorbbee DEl Atherosclerosis, apolipoprotein E and prevalence of dementia and Alzheimer disease in the Rotterdam study Lancet 1997, 349:151-4 10.1016/S0140-6736(96)09328-2 9111537
49. Notkola IL Sulkava R En J Erkinjuntti T Ehnholm C Kivinen P Tuomilehto J Nissinen A Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease Neuroepidemiology 1998, 17:14-20 10.1159/ 000026149 9549720
50. Roher AE Kuo YM Kokjohn KM Emmerling MR Gracon S Amyloid and lipids in the pathology of Alzheimer disease Amyloid 1999, 6:136-45 10439121
51. Bosel J Gandor F Harms C Synowitz M Harams U Djoufack PC Megow D Dirnagl U Hortnagl H Fink KB Endress M Neuroprotective effect of atorvastatin against glutamate-induced exitotoxicity in primary cortical neurons J Neurochem 2005, 92:1386-98 10.1111/j.1471-4159.2004.02980.x 15748157
52. Endres M Laufs U Effects of statins on Endothelium and Signaling Mechanisms Stroke 2004, 35:2708-11 10.1161/01.STR.0000143319.73503.38 15375300
53. Bannerman DM Chapman PF Kelly PAT Butcher SP Morris RGM Inhibition of Nitric Oxide Synthase Does Not Impair Spatial Learning J Neurosci 1994, 14:7415-14 7527843
54. Kopf SR Benton RS Kalfin R Giovannini MG NO synthesis inhibition decreases cortical ACh release and impairs retention of a conditioned response Brain Res 2001, 849:141-4 10.1016/S0006-8993(00)03148-6 11245824
55. Reddy OL Rajeshkaran K Paul V Evidence for an involvement of nitric oxide in memory of shock avoidance task in rats Indian J Physiol Pharmacol 2002, 46:119-22 12024951
56. Thomas T Monoamine oxidase-B inhibitors in the treatment of Alzheimers disease Neurobiol Aging 2000, 21:343-8 10.1016/S0197-4580(00)00100-7 10867219
57. Pitsikas N Rigamonti AE Cella SG Locatelli V Sala M Muller EE Effects of molsidomine on scopolamine-induced amnesia and hypermotility in the rat Eur J Pharmacol 2001, 426:193-200 10.1016/S0014-2999(01)01164-5 11527544
58. O'Dell TJ Hawkins RD Kandel ER Arancio O Tests of the roles of two diffusible substances in long-term potentiation: Evidence for nitric oxide as a possible early retrograde messenger Proc Natl Acad 1991, 88:11285-9 10.1073/pnas.88.24.11285
59. Pieper GM Diabetic induced endothelial dysfunction in rat aorta: Role of hydroxyl radicals Cardiovasc Res 1997, 34:145-56 10.1016/ S0008-6363(96)00237-4 9217884
60. Dimitrova KR Degroot KW Pacquing AM Suyderhoud JP Pirovic EA Murno TJ Wieneke JA Myers AK Kim YD Estradiol prevents homocysteine induced endothelial injury in male rats Cardiovasc Res 2002, 53:589-596 10.1016/ S0008-6363(01)00403-5 11861029
61. Allain CC Pool LS Chan CSG Richmound W Paul CF Enzymatic determination of total serum cholesterol Clin Chem 1974, 20:470-5 4818200
62. Ellman GL Courtney KD Valentino A Featherstone RM A new and rapid colorimetric determination of acetylcholinesterase activity Biochem pharmacol 1961, 7:88-95 10.1016/0006-2952(61)90145-9 13726518
63. Vos G Sachsse K Red cell and plasma cholinesterase activities in microsamples of human and animal blood determined simultaneously by a modified acetylthiocholine/DTNB procedure Toxicol Appl Pharmacol 1970, 16:764-72 10.1016/0041-008X(70)90082-7 5422218
64. Okhawa H Ohishi N Yagi K Assay of lipid peroxides in animals tissue by thiobarbituraic acid reaction Analytical Biochemistry 1979, 95:351-8 10.1016/0003-2697(79)90738-3 36810
65. Beutler RG Duron O Kelly B Reduced glutathion estimation J Lb Clinical Med 1963, 61:82
66. Lowry OH Rosebrough NJ Farr AL Randall RJ Protein measurement with folin-phenol reagent J Biol Chem 1951, 193:265-75 14907713